74
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials

, , , , , , & show all
Pages 871-885 | Published online: 08 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Wenhai Fu, Wenjun He, Yuexin Li, Yangxiao Chen, Jingyi Liang, Hui Lei, Lin Fu, Yanghang Chen, Ni Ren, Qian Jiang, Yi Shen, Ran Ma, Tao Wang, Xinni Wang, Nuofu Zhang, Dakai Xiao & Chunli Liu. (2021) Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis. Drug Delivery 28:1, pages 1007-1019.
Read now

Articles from other publishers (10)

Zonglin He, Sui Zhu, Kai Zhou, Ya Jin, Longkai He, Weipeng Xu, CheokUn Lao, Guosheng Liu & Shasha Han. (2021) Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta‐analysis. Pediatric Pulmonology 56:8, pages 2399-2412.
Crossref
Ruth B. Seabrook, Theresa R. Grover, Natalie Rintoul, Mark Weems, Sarah Keene, Beverly Brozanski, Robert DiGeronimo, Beth Haberman, Holly Hedrick, Jason Gien, Noorjahan Ali, Rachel Chapman, John Daniel, H. Allen Harrison, Yvette Johnson, Nicolas F. M. Porta, Michael Uhing, Isabella Zaniletti & Karna Murthy. (2021) Treatment of pulmonary hypertension during initial hospitalization in a multicenter cohort of infants with congenital diaphragmatic hernia (CDH). Journal of Perinatology 41:4, pages 803-813.
Crossref
Max Schlueter, Amélie Beaudet, Evan Davies, Binu Gurung & Andreas Karabis. (2020) Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal. BMC Pulmonary Medicine 20:1.
Crossref
Maja Petrovič & Igor Locatelli. (2019) A Bayesian Network Meta-analysis of Add-on Drug Therapies Specific for Pulmonary Arterial Hypertension. Annals of Pharmacotherapy 54:5, pages 423-433.
Crossref
Maja Petrovič & Igor Locatelli. (2020) Comparative effectiveness of pulmonary arterial hypertension drugs in treatment-naive patients: a network meta-analysis. Journal of Comparative Effectiveness Research 9:1, pages 7-22.
Crossref
Julie Birkmose Axelsen, Stine Andersen, Xiao-Qing Sun, Steffen Ringgaard, Janus Adler Hyldebrandt, Kondababu Kurakula, Marie-José Goumans, Frances S. de Man, Jens Erik Nielsen-Kudsk, Harm-Jan Bogaard & Asger Andersen. (2019) Effects of 6-mercaptopurine in pressure overload induced right heart failure. PLOS ONE 14:11, pages e0225122.
Crossref
David G. Kiely, David L. Levin, Paul M. Hassoun, Dunbar Ivy, Pei‐Ni Jone, Jumaa Bwika, Steven M. Kawut, Jim Lordan, Angela Lungu, Jeremy A. Mazurek, Shahin Moledina, Horst Olschewski, Andrew J. Peacock, G.D. Puri, Farbod N. Rahaghi, Michal Schafer, Mark Schiebler, Nicholas Screaton, Merryn Tawhai, Edwin J.R. Beek, Anton Vonk‐Noordegraaf, Rebecca Vandepool, Stephen J. Wort, Lan Zhao, Jim M. Wild, Jens Vogel‐Claussen & Andrew J. Swift. (2019) Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI). Pulmonary Circulation 9:3, pages 1-32.
Crossref
Picken, Fragkos, Eddama, Coghlan & Clapp. (2019) Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 8:4, pages 481.
Crossref
N A Karoli, S I Sazhnova & A P Rebrov. (2018) Pulmonary hypertension: reasonable selection of specific therapy. Systemic Hypertension 15:1, pages 45-50.
Crossref
Craig K. Docherty, Katie Yates Harvey, Kirsty M. Mair, Sinead Griffin, Nina Denver & Margaret R. MacLean. 2018. Sex-Specific Analysis of Cardiovascular Function. Sex-Specific Analysis of Cardiovascular Function 511 528 .